Six research universities including Yale pledged this week to support better access to drugs for developing nations.
A statement issued on Monday presents guidelines on the licensing of drugs discovered by university scientists. The schools call on pharmaceutical companies to provide lower cost medicines to poor countries.
John Soderstrom is managing director of Yale University’s Office of Cooperative Research. "What we’re trying to do is balance the need for protection on the part of the pharmaceutical companies who are investing the billions of dollars that its costs to bring a new drug to the marketplace with their need to maintain a profit. However there are certain parts of the world which just can’t afford to pay the price that would be required to get access to these drugs."
An international coalition of students called Universities Allied for Essential Medicines encourages schools to more strongly emphasize the role generic competition plays in lowering the cost of drugs.